Jeffrey A Cohen (Alit Bhatt)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 54

Top Topics

Myasthenia Gravis

Stem Cell Transplantation

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Neurology(R) neuroimmunology & neuroinflammation

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Mitzi J Williams, Lilyana Amezcua, Stanley L Cohan, Jeffrey A Cohen, Silvia R Delgado, Le H Hua, Elisabeth B Lucassen, Rebecca S Piccolo, Chloe R Koulouris, James M Stankiewicz
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses. Neurology 103 (3) (2024)
Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer S Graves, Scott S Zamvil, Scott D Newsome, Sean J Pittock
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Alise K Carlson, Moein Amin, Jeffrey A Cohen
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs 84 (3) (2024)
Ahmad Z Mahadeen, Alise K Carlson, Jeffrey A Cohen, Rachel Galioto, Justin R Abbatemarco, Sean J Pittock
Review of the Longitudinal Management of Autoimmune Encephalitis, Potential Biomarkers, and Novel Therapeutics. Neurology. Clinical practice 14 (4) (2024)
Kimberly A DiMauro, Carol Swetlik, Jeffrey A Cohen
Management of multiple sclerosis in older adults: review of current evidence and future perspectives. Journal of neurology 271 (7) (2024)
Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer S Graves, Scott S Zamvil, Scott D Newsome, Sean J Pittock
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Kimberly A DiMauro, Carol Swetlik, Jeffrey A Cohen
Management of multiple sclerosis in older adults: review of current evidence and future perspectives. Journal of neurology 271 (7) (2024)
Mitzi J Williams, Lilyana Amezcua, Stanley L Cohan, Jeffrey A Cohen, Silvia R Delgado, Le H Hua, Elisabeth B Lucassen, Rebecca S Piccolo, Chloe R Koulouris, James M Stankiewicz
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses. Neurology 103 (3) (2024)
Annalisa Morgan, Yadi Li, Nicolas R Thompson, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Daniel Ontaneda, Vineet Punia, Alexander Rae-Grant, Rachel Galioto, Sean J Pittock
Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis. Neurology 102 (4) (2024)
Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer S Graves, Scott S Zamvil, Scott D Newsome, Sean J Pittock
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Alise K Carlson, Moein Amin, Jeffrey A Cohen
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs (2024)
Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer S Graves, Scott S Zamvil, Scott D Newsome, Sean J Pittock
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Alise K Carlson, Moein Amin, Jeffrey A Cohen
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs 84 (3) (2024)
Kimberly A DiMauro, Carol Swetlik, Jeffrey A Cohen
Management of multiple sclerosis in older adults: review of current evidence and future perspectives. Journal of neurology 271 (7) (2024)
Kimberly A DiMauro, Carol Swetlik, Jeffrey A Cohen
Management of multiple sclerosis in older adults: review of current evidence and future perspectives. Journal of neurology (2024)
Alise K Carlson, Moein Amin, Jeffrey A Cohen
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs 84 (3) (2024)
Kimberly A DiMauro, Carol Swetlik, Jeffrey A Cohen
Management of multiple sclerosis in older adults: review of current evidence and future perspectives. Journal of neurology 271 (7) (2024)
Ahmad Z Mahadeen, Alise K Carlson, Jeffrey A Cohen, Rachel Galioto, Justin R Abbatemarco, Sean J Pittock
Review of the Longitudinal Management of Autoimmune Encephalitis, Potential Biomarkers, and Novel Therapeutics. Neurology. Clinical practice 14 (4) (2024)
Mitzi J Williams, Lilyana Amezcua, Stanley L Cohan, Jeffrey A Cohen, Silvia R Delgado, Le H Hua, Elisabeth B Lucassen, Rebecca S Piccolo, Chloe R Koulouris, James M Stankiewicz
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses. Neurology 103 (3) (2024)
Alise K Carlson, Moein Amin, Jeffrey A Cohen
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability. Drugs 84 (3) (2024)
Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer S Graves, Scott S Zamvil, Scott D Newsome, Sean J Pittock
Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Annalisa Morgan, Yadi Li, Nicolas R Thompson, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Daniel Ontaneda, Vineet Punia, Alexander Rae-Grant, Rachel Galioto, Sean J Pittock
Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis. Neurology 102 (4) (2024)
Ebtesam Alshehri, Jeffrey A Cohen, Daniel Ontaneda, Kunio Nakamura, Scott Husak, Thomas E Love, Robert J Fox, Farren Basil Shaw Briggs, Devon S Conway
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Jeffrey A Cohen
Commentary: Solomon AJ et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol (in press). Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Albert Aboseif, Yadi Li, Moein Amin, Brittany Lapin, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Vineet Punia, Alexander Rae-Grant, Rachel Galioto, Sean J Pittock
Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis. Neurology(R) neuroimmunology & neuroinflammation 11 (1) (2023)
Kunio Nakamura, Yufan Zheng, Kedar R Mahajan, Jeffrey A Cohen, Robert J Fox, Daniel Ontaneda
Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Stephen L Hauser, Ronald Zielman, Ayan Das Gupta, Jing Xi, Dee Stoneman, Goeril Karlsson, Derrick Robertson, Jeffrey A Cohen, Ludwig Kappos
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
John R Ciotti, Dana C Perantie, Brandon P Moss, Kathryn C Fitzgerald, Jeffrey A Cohen, Ellen M Mowry, Robert T Naismith, Salim Chahin
Perspectives and experiences with COVID-19 vaccines in people with MS. Multiple sclerosis journal - experimental, translational and clinical 8 (1) (2022)
Bruce Anthony Campbell Cree, Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi, Amit Bar-Or, Douglas Lorne Arnold, Hans-Peter Hartung, Xavier Montalbán, Eva K Havrdová, James K Sheffield, Neil Minton, Chun-Yen Cheng, Diego Silva, Ludwig Kappos, Jeffrey A Cohen
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (12) (2022)
Yang Mao-Draayer, Jeffrey A Cohen, Amit Bar-Or, May H Han, Barry Singer, Ian M Williams, Xiangyi Meng, Chelsea Elam, Jamie L Weiss, Gina Mavrikis Cox, Marina Ziehn, Bruce Anthony Campbell Cree, null null
Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study. Multiple sclerosis journal - experimental, translational and clinical 8 (3) (2022)
Jeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, Carrie M Hersh, Megan Hyland, Ellen M Mowry, Robert T Naismith, Maria L Naylor, Jacqueline Nicholas, Rajani Rajbhandar, Carol M Singh, Mar Tintore, Anna Zabalza, Tjalf Ziemssen, James R Williams, Xavier Montalban
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (7) (2022)
Jeffrey A Cohen, Fred D Lublin, Christoper Lock, Daniel Pelletier, Tanuja Chitinis, Munish Mehra, Yael Gothelf, Revital Aricha, Stacy Lindborg, Chaim Lebovits, Yossef Levy, Afsaneh Motamed Khorasani, Ralph Kern
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi, Richard Ac Clark, Maria Trojano, Krzysztof Selmaj, Bernard Mj Uitdehaag, Carmen Tur, Jens Wuerfel, Gabriele Dallmann, Julian Witte, Martina Sintzel, Olga Bobrovnikova, Jeffrey A Cohen
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (14) (2022)
Jutta Gärtner, Stephen L Hauser, Amit Bar-Or, Xavier Montalban, Jeffrey A Cohen, Anne H Cross, Kumaran Deiva, Habib Ganjgahi, Dieter A Häring, Bingbing Li, Ratnakar Pingili, Krishnan Ramanathan, Wendy Su, Roman Willi, Bernd Kieseier, Ludwig Kappos
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (10) (2022)
Corey C Ford, Jeffrey A Cohen, Andrew D Goodman, J William Lindsey, Robert P Lisak, Christopher Luzzio, Amy Pruitt, John Rose, Horea Rus, Jerry S Wolinsky, Shaul E Kadosh, Emily Bernstein-Hanlon, Yafit Stark, Jessica K Alexander
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (11) (2022)
Gabrielle Macaron, Jean Khoury, James Bena, Meagan Seay, Robert A Bermel, Jeffrey A Cohen, Mary R Rensel
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorder. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (11) (2021)
Bruce Anthony Campbell Cree, Jeffrey A Cohen, Anthony T Reder, Davorka Tomic, Diego Silva, Daniela Piani Meier, Annik K Laflamme, Shannon Ritter, David Leppert, Ludwig Kappos
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (14) (2021)
Sarah B Simmons, Jeffrey A Cohen
MRI findings in blinded trials should be available to treating physicians - No. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (6) (2021)
Deja R Rose, Ahmad Z Mahadeen, Alise K Carlson, Sarah Marie Planchon, Jennifer Sedlak, Scott Husak, Robert A Bermel, Jeffrey A Cohen, Brandon P Moss
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 7 (4) (2021)
Justin R Abbatemarco, Jeffrey A Cohen, Belinda L Udeh, Sunakshi Bassi, Mary R Rensel
Multiple Sclerosis Wellness Shared Medical Appointment Model: A Pilot Study. International journal of MS care 23 (5) (2021)
Jeffrey A Cohen, Michelle H Cameron, Myla D Goldman, Andrew D Goodman, Aaron E Miller, Anne Rollins, Lily Llorens, Rajiv Patni, Robert Elfont, Reed Johnson
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Brandon P Moss, Kedar R Mahajan, Robert A Bermel, Kelsey Hellisz, Le H Hua, Timothy Hudec, Scott Husak, Marisa P McGinley, Daniel Ontaneda, Zhini Wang, Malory Weber, Paula Tagliani, Simón Cárdenas-Robledo, Anna Zabalza, Georgina Arrambide, Pere Carbonell-Mirabent, Marta Rodríguez-Barranco, Jaume Sastre-Garriga, Mar Tintore, Xavier Montalban, Morgan Douglas, Esther Ogbuokiri, Berna Aravidis, Jeffrey A Cohen, Ellen M Mowry, Kathryn C Fitzgerald
Multiple sclerosis management during the COVID-19 pandemic. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (10) (2020)
Carolyn H Goldschmidt, Jeffrey A Cohen
The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 17 (3) (2020)
Liesbet M Peeters, Tina Parciak, Clare Walton, Lotte Geys, Yves Moreau, Edward De Brouwer, Daniele Raimondi, Ashkan Pirmani, Tomas Kalincik, Gilles Edan, Steve Simpson Yap, Luc De Raedt, Yann Dauxais, Clément Gautrais, Paulo R Rodrigues, Landon McKenna, Nikola Lazovski, Jan Hillert, Lars Forsberg, Timothy Spelman, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden M Middleton, Salter Amber, Bruce F Bebo, Juan I Rojas, Anneke Van Der Walt, Helmut Butzkueven, Ingrid van der Mei, Rumen Ivanov, Kerstin Hellwig, Guilherme Sciascia do Olival, Jeffrey A Cohen, Wim Van Hecke, Chu-Yueh Guo, Melinda Magyari, Doralina Guimarães Brum, Ricardo Alonso, Richard Nicholas, Johana Bauer, Anibal Chertcoff, Jérôme de Sèze, Céline Louapre, Giancarlo Comi, Nick Rijke
COVID-19 in people with multiple sclerosis: A global data sharing initiative. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (10) (2020)
Olga Ciccarelli, Jeffrey A Cohen, Alan Thompson
Response of the multiple sclerosis community to COVID-19. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (10) (2020)
Laura E Baldassari, Sarah Marie Planchon, Robert A Bermel, Kunio Nakamura, Elizabeth Fisher, Jenny Feng, Ken E Sakaie, Daniel Ontaneda, Jeffrey A Cohen
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)
Brandon P Moss, Jeffrey A Cohen
The emergence of follow-on disease-modifying therapies for multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 25 (12) (2019)
Jeffrey A Cohen, Amit Bar-Or, Bruce A C Cree, Yang Mao-Draayer, May H Han, Barry Singer, Ann Jannu, Scott Kolodny, Xiangyi Meng, Ryan C Winger
The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod. Multiple sclerosis journal - experimental, translational and clinical 5 (1) (2019)
Andrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, Mary Rensel
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)
Jenny Feng, Erik Offerman, Jian Lin, Elizabeth Fisher, Sarah Marie Planchon, Ken Sakaie, Mark Lowe, Kunio Nakamura, Jeffrey A Cohen, Daniel Ontaneda
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 5 (2) (2019)
Marisa P McGinley, Philip A Cola, Robert J Fox, Jeffrey A Cohen, John J Corboy, Deborah M Miller
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (12) (2019)
Jeffrey A Cohen, Nadia Tenenbaum, Jeffrey A Cohen, Ying Zhang, Ludwig Kappos
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results. Therapeutic advances in neurological disorders 12 (2019)
Jeffrey A Cohen, Maria Trojano, Ellen M Mowry, Bernard Mj Uitdehaag, Stephen C Reingold, Kathryn C Fitzgerald
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (1) (2019)
Lauren Strober, John DeLuca, Ralph Hb Benedict, Adam Jacobs, Jeffrey A Cohen, Nancy D Chiaravalloti, Lynn D Hudson, Richard A Rudick, Nicholas G LaRocca, null null
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 25 (13) (2018)